Menitorix is a vaccine used primarily for the immunization of infants and children against diseases caused by Haemophilus influenzae type b (Hib) and Neisseria meningitidis serogroup C (MenC). These bacteria can cause serious and potentially life-threatening infections such as meningitis and septicemia. Menitorix is administered as an injection and works by stimulating the body's immune system to produce antibodies against these bacteria, providing protection against these infections. It is typically included in the childhood vaccination schedule and is known for its role in significantly reducing the incidence of these diseases in populations where the vaccine is widely used. As with any vaccine, the use of Menitorix should be based on official recommendations, taking into account factors such as age, health status, and local epidemiology of the diseases.